Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc. is a commercial-stage medical technology company focused on developing and manufacturing continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems that measure glucose levels using an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.